Skip to main content
. 2018 Jul 5;103(10):1654–1661. doi: 10.3324/haematol.2018.189514

Figure 4.

Figure 4.

Relapse, death in remission, relapse-free survival and overall survival within the everolimus randomisation: (A) Cumulative incidence of relapse; (B) cumulative incidence of death in remission; (C) relapse-free survival; (D) overall survival.